Evidence map›Paper›PMID 26286693›Full record

ArticlemBio2015

An Alternative Terminal Step of the General Secretory Pathway in Staphylococcus aureus.

Arryn Craney, Melissa M Dix, Ramkrishna Adhikary, Benjamin F Cravatt, Floyd E Romesberg

Open access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Gallium Resistance inApplied microbiology (Basel, Switzerland) · 2025
    Article
  4. Single Atom Engineered Antibiotics Overcome Bacterial Resistance.Advanced materials (Deerfield Beach, Fla.) · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Microbial cell (Graz, Austria) · 2017
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Arryn CraneyDepartment of Chemistry, The Scripps Research Institute, La Jolla, California, USA.
Melissa M DixThe Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, La Jolla, California, USA.
Ramkrishna AdhikaryDepartment of Chemistry, The Scripps Research Institute, La Jolla, California, USA.
Benjamin F CravattThe Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, La Jolla, California, USA.
Floyd E RomesbergDepartment of Chemistry, The Scripps Research Institute, La Jolla, California, USA floyd@scripps.edu.
Scripps Research Institute · US

Funding

Beyond translocation - non-canonical activities of bacterial signal peptidaseR21AI109809 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ROMESBERG, FLOYD E. · 2015 to 2016
$499k
NIAID NIH HHS AI109809NIAID NIH HHS R21 AI109809
6 · The paper itself

Abstract

Type I signal peptidase (SPase) is essential for viability in wild-type bacteria because the terminal step of the bacterial general secretory pathway requires its proteolytic activity to release proteins from their membrane-bound N-terminal leader sequences after translocation across the cytoplasmic membrane. Here, we identify the Staphylococcus aureus operon ayrRABC (SA0337 to SA0340) and show that once released from repression by AyrR, the protein products AyrABC together confer resistance to the SPase inhibitor arylomycin M131 by providing an alternate and novel method of releasing translocated proteins. Thus, the derepression of ayrRABC allows cells to bypass the essentiality of SPase. We demonstrate that AyrABC functionally complements SPase by mediating the processing of the normally secreted proteins, albeit in some cases with reduced efficiency and either without cleavage or via cleavage at a site N-terminal to the canonical SPase cleavage site. Thus, ayrRABC encodes a secretion stress-inducible alternate terminal step of the general secretory pathway. IMPORTANCE : Addressing proteins for proper localization within or outside a cell in both eukaryotes and prokaryotes is often accomplished with intrinsic signals which mediate membrane translocation and which ultimately must be removed. The canonical enzyme responsible for the removal of translocation signals is bacterial type I signal peptidase (SPase), which functions at the terminal step of the general secretory pathway and is thus essential in wild-type bacteria. Here, we identify a four-gene operon in S. aureus that encodes an alternate terminal step of the general secretory pathway and thus makes SPase nonessential. The results have important implications for protein secretion in bacteria and potentially for protein trafficking in prokaryotes and eukaryotes in general.

Indexed as

Bacterial ProteinsEndopeptidasesMembrane ProteinsModels, MolecularOperonProtein ConformationProtein Sorting SignalsProtein TransportProteomeSecretory PathwaySerine EndopeptidasesStaphylococcus aureusBacterial ProteinsEndopeptidasesglutamic acid-specific endopeptidase, Staphylococcus aureusMembrane ProteinsProtein Sorting SignalsProteomeSerine Endopeptidasestype I signal peptidase

Identifiers

PMID26286693
PMCPMC4542188
OpenAlexW2146290818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.